Camber launches generic Abilify OS
Camber initially launched Aripiprazole Tablets in 2015, as one of the first generic alternatives to Abilify,
Camber added Aripiprazole Oral Solution to its product line, complementing the existing product family that included Aripiprazole Tablets.
The company initially launched Aripiprazole Tablets in 2015, as one of the first generic alternatives to Abilify, significantly expanding patient access to this medication.
Aripiprazole Oral Solution is indicated for the treatment of:
- Schizophrenia;
- Acute treatment of manic and mixed episodes associated with Bipolar I Disorder;
- Irritability associated with Autistic Disorder; and
- Treatment of Tourette’s Disorder.
Aripiprazole Oral Solution 1 mg/ml is available in 150 ml child-resistant bottles with a calibrated oral dosing cup.